Risk factors associated with metastatic site failure in patients with high-risk neuroblastoma.
Clin Transl Radiat Oncol
; 34: 42-50, 2022 May.
Article
in En
| MEDLINE
| ID: mdl-35345864
ALK, anaplastic lymphomakinase; BuMel, Busulfan-Melphalan; CBCT, Cone Beam Computed Tomography; CCG, Children's Cancer Group; CI, Confidence interval; CNS, Central Nervous System; COG, Children's Oncology Group; CPHr, Cox proportional hazards regression; CT, Computed Tomography; Cor, Correlation; GD2, Disialoganglioside; HR, Hazard Ratio; IMRT, Intensity Modulated Radiotherapy; LDH, lactate dehydrogenase; MEC, Melphalan-Etoposide-Carboplatin; MIBG, meta-iodobenzylguanidine; MR, Magnetic Resonance Imaging; MS, Metastatic Sites; MSF, Metastatic Site Failure; MYCN, v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog, MYCN proto-oncogene; Maint, Maintenance; Met, Metastasis; SIOP, International Society of Pediatric Oncology; SIOPEN, European SIOP Neuroblastoma Group; cphfR, Cox proportional hazards frailty regression
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Clin Transl Radiat Oncol
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Ireland